Living cells are composed of diverse biomolecules. Whether abundant or rare, these molecules help maintain cell functions and keep our bodies healthy. Changes in the amount of a biomolecule can also affect how well our bodies operate. Hence, researchers advance biological research by identifying existing and novel molecules that contribute to health and disease. These molecules are called biomarkers.
But what has driven the surge in biomarker research? The answer lies in mass spectrometry (MS).
MS analysis characterizes small molecules as well as larger molecules such as proteins at a high-throughput rate. MS’s capabilities have spearheaded the wholesale characterization of proteins and metabolites in samples. Known as proteomics and metabolomics, researchers can now choose from one of many mass spectrometers to profile biomolecules. Even so, MS is still time-intensive and costly since owning and maintaining a mass spectrometer can be expensive. The steps involved with tissue culture processing are also just as complex.
In this article, we will discuss the basics of MS and walk through the MS pipeline as it pertains to tissue cultures, a type of biological sample. We will then discuss how MS helps researchers use tissue cultures to advance clinical research. Finally, we will show how our leasing program helps you leverage the power of MS as you develop your biomarker discovery workflows.
MS is a technique that measures analytes, any compound of interest. These include proteins, amino acids, lipids, fatty acids, complex carbohydrates, and simple sugars.. The mass spectrometer identifies each analyte once it separates them by their chemical characteristics. All mass spectrometers contain four components:
Researchers can also select from three types of MS depending on the kinds of biomolecules being profiled:
Mass spectrometry provides a useful tool for characterizing cultured cells’ chemical composition. However, undertaking such a study features a multi-step process that must be conducted carefully.
MS is an essential tool for obtaining high-throughput and high-resolution metabolite and protein profiles. Such assays provide valuable insights into protein-protein interactions at the cellular and subcellular levels.
Researchers can also harness the power of MS as they evaluate three-dimensional (3D) cell cultures for studying disease and developing pharmaceuticals. Known as organoids and spheroids, they are derived from stem cells and mimic a given organ's key functional and structural aspects.
Excedr is, first and foremost, a scientific equipment leasing company. Suppose you want to advance your proteomics and metabolomics research but find the upfront costs of buying a mass spectrometer too expensive for your budget. In that case, we can lease you one instead, helping you preserve working capital and extend your cash runway with significantly lower upfront costs and manageable monthly payments.
We do not carry an inventory but instead acquire the exact mass spectrometer you want when you need it from the most well-known vendors—or any manufacturer you choose. Here are just some of the vendors we work with:
Researchers across the R&D sector are using tissue cultures in important preclinical research. Characterizing the biomolecules that comprise these cells is critical for profiling cellular behaviors and developing novel therapeutics for treating disease.
Excedr’s leasing program helps you acquire the exact mass spectrometer you’ll need to advance your proteomics and metabolomics research. Once you know the kinds of biomolecules you’re testing, the ways you’ll process your samples, and the ways you’ll analyze your data, speak with us to start the approval process.